Pharma · Private company
AbbVie (prior sponsor, Abbott)
Track this companyFree. Adds AbbVie (prior sponsor, Abbott) to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ABT-126Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ABT-126Phase 2 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- ABT-263Phase 2 · Chronic Lymphoid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VeliparibPhase 1 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)PHASE1 · COMPLETED · started Jan 13, 2014ClinicalTrials.gov NCT01671904 · fetched Nov 12, 2026
- A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic LeukemiaPHASE1 · COMPLETED · started Nov 29, 2012ClinicalTrials.gov NCT01685892 · fetched Nov 12, 2026
- Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseasePHASE2 · TERMINATED · started Sep 1, 2012ClinicalTrials.gov NCT01690195 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaPHASE2 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01678755 · fetched Nov 12, 2026
- This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseasePHASE2 · TERMINATED · started Aug 1, 2012ClinicalTrials.gov NCT01676935 · fetched Nov 12, 2026
- A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaPHASE2 · COMPLETED · started May 1, 2012ClinicalTrials.gov NCT01655680 · fetched Nov 12, 2026
- Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid TumorPHASE1 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01123876 · fetched Nov 12, 2026
- A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesPHASE1_PHASE2 · COMPLETED · started Nov 1, 2006ClinicalTrials.gov NCT00406809 · fetched Nov 12, 2026